[Systemic paracoccidioidomycosis with central nervous system involvement]

Rev Soc Bras Med Trop. 1999 Jul-Aug;32(4):439-42. doi: 10.1590/s0037-86821999000400015.
[Article in Portuguese]

Abstract

A clinical case of a patient bearing systemic paracoccidioidomycosis with regional ganglionic and oral exposure and later pulmonary involvement is presented. The patient was treated with specific drugs (amphotericin B, itraconazole, sulfamethoxazole-trimethoprim) and followed throughout a 6-year period and eventually died showing an extensive involvement of the central nervous system.

Publication types

  • Case Reports
  • English Abstract
  • Review

MeSH terms

  • Adult
  • Anti-Infective Agents / therapeutic use
  • Antifungal Agents / therapeutic use
  • Central Nervous System Diseases / diagnosis
  • Central Nervous System Diseases / drug therapy
  • Central Nervous System Diseases / etiology*
  • Drug Therapy, Combination
  • Fatal Outcome
  • Humans
  • Itraconazole / therapeutic use
  • Male
  • Paracoccidioidomycosis / complications*
  • Paracoccidioidomycosis / diagnosis
  • Paracoccidioidomycosis / drug therapy
  • Trimethoprim / therapeutic use
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Infective Agents
  • Antifungal Agents
  • Itraconazole
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Trimethoprim